Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection
about
Do the tuberculin skin test and the QuantiFERON-TB Gold in-tube test agree in detecting latent tuberculosis among high-risk contacts? A systematic review and meta-analysisRates of latent tuberculosis in health care staff in RussiaThe HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunityMultiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigensEnzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection.Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay.Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contactsIn vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response.Prevalence and risk factors for tuberculosis infection among hospital workers in Hanoi, Viet Nam.CD69 expression on CD4+ T lymphocytes after in vitro stimulation with tuberculin is an indicator of immune sensitization against Mycobacterium tuberculosis antigensIn vivo expression of innate immunity markers in patients with Mycobacterium tuberculosis infection.Assessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits.Revisiting annual screening for latent tuberculosis infection in healthcare workers: a cost-effectiveness analysis.Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda.Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis.Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin testIn vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K.Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots.Cytokine response to antigen stimulation of whole blood from patients with Mycobacterium ulcerans disease compared to that from patients with tuberculosis.Risk factors for latent tuberculosis infection in close contacts of active tuberculosis patients in South Korea: a prospective cohort study.Tuberculosis 2004: challenges and opportunities.The BCG World Atlas: a database of global BCG vaccination policies and practices.Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection.Genetic analysis of Mycobacterium avium complex strains used for producing purified protein derivatives.Comparative genomics of Esx genes from clinical isolates of Mycobacterium tuberculosis provides evidence for gene conversion and epitope variation.Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant Recipients.Serodiagnosis efficacy and immunogenicity of the fusion protein of Mycobacterium tuberculosis composed of the 10-kilodalton culture filtrate protein, ESAT-6, and the extracellular domain fragment of PPE68.Testing for latent tuberculosis.Can social history variables predict prison inmates' risk for latent tuberculosis infection?Long-Term immune responses to Coxiella burnetii after vaccination.Feasibility of the Interferon-γ Release Assay for the Diagnosis of Genitourinary Tuberculosis in an Endemic Area.Superoxide dismutase A antigens derived from molecular analysis of sarcoidosis granulomas elicit systemic Th-1 immune responses.Evaluation of the diagnostic utility of a whole-blood interferon-gamma assay for determining the risk of exposure to Mycobacterium tuberculosis in Bacille Calmette-Guerin (BCG)-vaccinated individuals.Dynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy.Comparison of intracellular cytokine flow cytometry and an enzyme immunoassay for evaluation of cellular immune response to active tuberculosis.Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complicationsEvaluation of an in vitro assay for gamma interferon production in response to Mycobacterium tuberculosis infectionsThe major histocompatibility complex haplotype affects T-cell recognition of mycobacterial antigens but not resistance to Mycobacterium tuberculosis in C3H mice.A clinical approach to paediatric tuberculosis in Canada.Performance of QuantiFERON-TB Gold In-Tube test and Tuberculin Skin Test for diagnosis of latent tuberculosis infection in BCG vaccinated health care workers.
P2860
Q26780382-CE4D868D-5C0C-4B9A-A999-E97666CACFE6Q28469137-97DAE54E-00BB-4704-B571-F5482FC54F8BQ28727776-D905A373-E6ED-4914-AC97-C47C6DB2A58BQ28742421-2D5D1A0C-D412-46F7-A616-2D05FFA51CD7Q30489177-2140F605-BE36-483C-8014-724A94FED9FFQ33236625-B0835DB3-3314-49B8-A737-79596B484701Q33312938-296880FF-A140-40D6-A6E8-7674DF22FF3BQ33429956-A52855D0-BBDB-42F0-84A5-526DDB7F761CQ33497330-1F8C9F80-0262-4710-95C9-5F86F5EFF22DQ33593498-4E082753-5618-4B10-AE50-1D8D01595C1EQ33662586-FB52A7E3-25B7-4E13-935D-E7131ACA62C9Q33699313-9F4D025C-C589-4291-81FB-49FAAE2C0EE2Q33702764-72C436F0-2A8C-4DC0-A7CA-4100937AA59AQ33847573-BE3978CD-C08D-46E1-8469-A2F2B9C8D6E8Q33856516-FCF3FABC-4A6D-4EA1-BAA8-F762E71CBE34Q33866395-D41EC680-B08A-4A0D-82CF-08E91AEE9345Q33944681-52A3D0AB-D215-4C25-97F6-E0925F78A387Q34128381-A129EC76-A909-4C3D-AA87-1F3FCB1DE1F1Q34429309-BBDB4327-AAE5-4014-856E-15F92092C56CQ34544215-4570754B-2390-42A3-8D22-B5CE98BEC5AFQ34655115-2E83BAD3-86AF-4B68-93B1-A3515221FAAFQ34708175-830B0CC6-044D-49F8-A162-E1B44AC75023Q34781367-5C5F8677-0597-40B9-922E-DFC957DFAEE7Q35023372-B201AC68-9C03-4DB0-AF24-B0369C6F4102Q35273109-313A398A-E115-478F-A47C-186DDFE850BBQ35818931-5A42ECC6-7FE0-4EEC-A5E0-F0F51BEA4A98Q35867222-A1EC6396-21CD-48DF-9739-DF600B0C7E5EQ36148582-C3ADFA5E-80B2-4720-8D01-C81DBA3FBBCFQ36519985-2973373B-8FCC-4765-8E6A-1A1546BC316FQ36606769-6AB43CFF-F631-44BB-9636-C5945102301AQ36632619-F24246FB-5B3C-4947-9003-5086446E8673Q36657328-76994B72-FBAB-4A24-99DA-F4286F5DBF73Q36777647-14156C9C-3F6A-4EF0-9B7D-725434204E37Q36923535-A81E0673-6074-46BD-8014-825A907BA87BQ37116521-97C6182F-06B7-4150-94EA-33E59C6FC0B6Q37227240-90FED309-0C2E-4A1A-BF98-5FCEC2013C1EQ37595160-58EEC9F8-A817-40F3-854E-5D0357CCB9A5Q37623959-9CC43DC5-961B-494F-BBFA-79811D748CFFQ37658363-4838FF27-2D76-43E8-8460-33063B2DF749Q37685543-0A9EACE3-22C3-4E54-929E-8DEF932875CC
P2860
Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Comparison of a whole-blood in ...... cterium tuberculosis infection
@ast
Comparison of a whole-blood in ...... cterium tuberculosis infection
@en
Comparison of a whole-blood in ...... cterium tuberculosis infection
@nl
type
label
Comparison of a whole-blood in ...... cterium tuberculosis infection
@ast
Comparison of a whole-blood in ...... cterium tuberculosis infection
@en
Comparison of a whole-blood in ...... cterium tuberculosis infection
@nl
prefLabel
Comparison of a whole-blood in ...... cterium tuberculosis infection
@ast
Comparison of a whole-blood in ...... cterium tuberculosis infection
@en
Comparison of a whole-blood in ...... cterium tuberculosis infection
@nl
P2093
P1476
Comparison of a whole-blood in ...... cterium tuberculosis infection
@en
P2093
A A Lardizabal
G H Mazurek
J Bernardo
J S Rothel
M F Iademarco
W R Bishai
P304
P407
P577
2001-10-10T00:00:00Z